COVID-19 Vaccine Janssen®

The National Immunisation Office is prioritising keeping the Clinical Guidelines, Bulletins and the Quick Reference Guide up to date. We have limited access to files as a result of the recent cyber attack on our health service. 

The European Medicines Agency authorised the use of the COVID‐19 Vaccine Janssen® in March 2021.

This page contains information to support vaccinators who are administering the COVID‐19 Vaccine Janssen®

Janssen Summary Sheet

Materials for Vaccinators

Please note if you are using TrackVax Vaccine Reconcilliation should be done through this system instead. 

Information from the European Medicines Agency

Information from the World Health Organization

Go to the COVID-19 Page for Health Professionals

This page was updated on 18 June 2021